Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation

Vipawee S. Chat(Keck Hospital of USC), April W. Armstrong(University of California, Los Angeles), G. Michael Lewitt(Illinois Public Health Institute), Christopher T. Ritchlin(University of Rochester Medical Center), Joel M. Gelfand(University of Pennsylvania), Stacie Bell(National Psoriasis Foundation), Abby S. Van Voorhees(Eastern Virginia Medical School), Mark Lebwohl(Mount Sinai Hospital), Kristina Callis Duffin(University of Utah), Amit Garg(Northwell Health), Ana‐Maria Orbai(Johns Hopkins University), Dafna D. Gladman(Toronto Western Hospital), George Han(Icahn School of Medicine at Mount Sinai), Paul S. Yamauchi(University of California, Los Angeles), Evan Siegel(Arthritis and Rheumatism Associates), Jóhann E. Guðjónsson(University of Michigan), Leon Kircik(University School), George M. Martin(Martin University), Richard G. Langley(Dalhousie University), Christoph T. Ellebrecht(University of Pennsylvania), Jason E. Hawkes(University of California, Davis), Seemal R. Desai(The University of Texas Southwestern Medical Center), Paige Kingston(Keck Hospital of USC), Kelly M. Cordoro(University of California, San Francisco), George Gondo(National Psoriasis Foundation), Wilson Liao(University of California, San Francisco), Veronica Richardson(University of Pennsylvania), Sergio Schwartzman(Medical Research Associates), Lawrence J. Green(Aesthetic Surgery Center), Soumya M. Reddy(New York University), John Koo(University of California, San Francisco), Jeffrey M Weinberg, Kevin Winthrop(Oregon Health & Science University), Elizabeth B. Wallace(University of Colorado Anschutz Medical Campus), Steven R. Feldman(Wake Forest University)
Journal of the American Academy of Dermatology
February 7, 2024
Cited by 19


Related Papers